(NYSE: ELAN) Elanco Animal Health's forecast annual revenue growth rate of 3.67% is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 4.33%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.4%.
Elanco Animal Health's revenue in 2025 is $4,427,000,000.On average, 6 Wall Street analysts forecast ELAN's revenue for 2025 to be $2,255,500,232,056, with the lowest ELAN revenue forecast at $2,239,379,086,536, and the highest ELAN revenue forecast at $2,266,893,302,858. On average, 6 Wall Street analysts forecast ELAN's revenue for 2026 to be $2,358,483,361,186, with the lowest ELAN revenue forecast at $2,330,788,862,183, and the highest ELAN revenue forecast at $2,382,115,291,786.
In 2027, ELAN is forecast to generate $2,446,632,652,534 in revenue, with the lowest revenue forecast at $2,406,748,958,384 and the highest revenue forecast at $2,478,017,731,708.